Side effects of stopping metoprolol
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Stopping Metoprolol
Cardiovascular Rebound Effects
Stopping metoprolol, especially abruptly, can lead to significant cardiovascular rebound effects. Research indicates that patients with ischemic heart disease who discontinued metoprolol experienced a rebound increase in basal heart rate and heart rate response to orthostatic testing within three weeks of withdrawal . This rebound phenomenon is likely due to increased beta-adrenoceptor responsiveness, which can unmask ischemic symptoms and lead to increased cardiac symptoms and mental distress .
Exacerbation of Heart Failure Symptoms
In patients with dilated cardiomyopathy, withdrawal of metoprolol has been shown to cause a deterioration in heart function. Specifically, stopping metoprolol led to an increase in heart rate and left atrial dimension, along with a decrease in ejection fraction, indicating worsening heart failure . These patients often required readministration of metoprolol to stabilize their condition, highlighting the critical role of the drug in managing severe heart failure .
Mental and Psychological Symptoms
Discontinuing metoprolol can also result in mental and psychological symptoms. A study involving patients with ischemic heart disease found that mental symptoms and increased cardiac symptoms were significantly more frequent in the metoprolol group after withdrawal compared to the placebo group . Additionally, patients reported vivid and bizarre dreams, sleep disturbances, and increased anxiety upon stopping metoprolol, which are attributed to the drug's central nervous system (CNS) effects .
Increased Risk of COPD Exacerbations
For patients with chronic obstructive pulmonary disease (COPD), stopping metoprolol may lead to an increased risk of exacerbations. A randomized trial found that metoprolol was associated with a higher risk of exacerbations leading to hospitalization, suggesting that discontinuation could potentially worsen COPD symptoms . This highlights the need for careful management and monitoring when considering stopping metoprolol in COPD patients.
Clinical Implications and Recommendations
Given the potential for significant side effects upon stopping metoprolol, it is crucial to approach discontinuation with caution. Gradual tapering of the dose, rather than abrupt cessation, is recommended to mitigate rebound effects and other adverse symptoms . Close monitoring of patients during the withdrawal period is essential to manage any emerging symptoms effectively and to reinstitute treatment if necessary Waagstein1989Olsson1984.
Conclusion
Stopping metoprolol can lead to a range of side effects, including cardiovascular rebound effects, exacerbation of heart failure symptoms, mental and psychological disturbances, and increased risk of COPD exacerbations. Gradual tapering and close monitoring are essential strategies to minimize these risks and ensure patient safety.
Sources and full results
Most relevant research papers on this topic